Adipocyte fatty acid binding protein during refeeding of female patients with anorexia nervosa.
BACKGROUND
Adipocyte fatty acid binding protein (A-FABP) has been suggested to play an important role in fat metabolism linking obesity and the metabolic syndrome. Increasing A-FABP plasma levels were observed during greatest weight loss after bariatric surgery suggesting that A-FABP may indicate changes in fat mass in dynamic situations.


OBJECTIVE
As there are no data on weight gain, we investigated the effect of refeeding anorexic patients on body composition and A-FABP plasma levels.


METHODS
Parameters of glucose and lipid metabolism as well as plasma levels of leptin and A-FABP were prospectively assessed in 16 female patients with anorexia nervosa during inpatient weight restoration. Body composition was determined by multifrequency body impedance analysis.


RESULTS
After 28 days, fat mass increased from 4.4 +/- 2.5 kg at baseline to 5.5 +/- 2.2 kg (P < 0.01), constituting 40% of total weight gain. Conversely, A-FABP concentrations decreased from 32.56 +/- 35.59 ng/ml at baseline to 21.27 +/- 13.68 ng/ml (P < 0.05), which corresponds to a significant decrease in the proportion of A-FABP per kilogram fat mass from 7.86 +/- 5.23 to 4.09 +/- 2.12 ng/ml/kg (P </= 0.001). Variation in A-FABP plasma concentration was predictive for changes in total cholesterol levels (adjusted r (2) = 0.239; P < or = 0.05), but not for gain in weight, fat mass, or percent body fat.


CONCLUSIONS
The present results indicate that variation in A-FABP plasma levels reflect alterations in nutritional status in patients with anorexia nervosa.
Engl
Julia
J
Department of Internal Medicine I, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Tschoner
Alexander
A
Willis
Michael
M
Schuster
Ingrid
I
Kaser
Susanne
S
Laimer
Markus
M
Biebl
Wilfried
W
Patsch
Josef R
JR
Mangweth
Barbara
B
Ebenbichler
Christoph F
CF
D017667:Adipocytes / Q000201:enzymology; D000293:Adolescent; D000328:Adult; D000856:Anorexia Nervosa / Q000097:blood / Q000178:diet therapy*; D001823:Body Composition; D015992:Body Mass Index; D052018:Bulimia Nervosa / Q000097:blood / Q000178:diet therapy*; D017097:Electric Impedance; D004797:Enzyme-Linked Immunosorbent Assay; D050556:Fatty Acid-Binding Proteins / Q000097:blood*; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood; D016555:Matched-Pair Analysis; D008875:Middle Aged; D012044:Regression Analysis; D015430:Weight Gain; D055815:Young Adult
D050556:Fatty Acid-Binding Proteins; D020738:Leptin